FDA approves Sanofi Pasteur's meningococcal vaccine
Links shared publicly online about this topic.
- 339total visits
FDA approves Sanofi Pasteur's meningococcal vaccine
View full resource at news-medical.net
Tags: Vaccination, Meningitis, Diet and Nutrition, Drug, FDA, Vaccine, Sanofi-Aventis, News
Most Recently Shared on April 25, 2011 at 11:44 am By:
Meningitis News: FDA approves Sanofi Pasteur's meningococcal vaccine: Sanofi Pasteur, the vaccines division of t... http://bit.ly/eCrvvc
FDA Licenses Sanofi Pasteur's New Influenza Vaccine Delivered By Intradermal Microinjection
medicalnewstoday.com — “Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced the U.S. Food and Drug Administration (FDA) has approved the company's supplemental biologics license appli” View full resource at medicalnewstoday.com
Most Recently Shared on May 13, 2011 at 7:05 am By:
MNT Colds / Flu News Health News
FDA Licenses Sanofi Pasteur's New Influenza Vaccine Delivered By Intradermal Microinjection http://mnt.to/3VNC #flu
Microinjection Flu Vaccine Product Approved by FDA -- AAFP News Now -- American Academy of Family Physicians
aafp.org — “Family physicians soon may have a new weapon in their armamentarium to prevent influenza. Pharmaceutical manufacturer Sanofi Pasteur said in a May 10 news release that the FDA has approved the company’s license application for Fluzone Intradermal, making it the first influenza vaccine that uses a microinjection system to be licensed in the United States.” View full resource at aafp.org
Most Recently Shared on May 12, 2011 at 11:48 pm By:
Microinjection Flu Vaccine Product Approved by FDA: Family physicians soon may have a new weapon in their armame... http://bit.ly/mNg7IL
Fluzone Intradermal Vaccine Approved for Influenza Immunization - MPR
empr.com — “Sanofi Pasteur announced that the FDA has approved Fluzone Intradermal (influenza virus vaccine) for the active immunization of adults 18--64 years old against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine.” View full resource at empr.com
Most Recently Shared on May 10, 2011 at 3:23 pm By:
MPR News: Fluzone Intradermal Vaccine Approved for Influenza Immunization: Sanofi Pasteur announced that the FDA... http://bit.ly/jUp92u
Fluzone Intradermal Vaccine Approved for Influenza Immunization - ONA
oncologynurseadvisor.com — “Sanofi Pasteur announced that the FDA has approved Fluzone Intradermal (influenza virus vaccine) for the active immunization of adults 18--64 years old against influenza disease caused by influenza virus subtypes A and type B contained in the vaccine.” View full resource at oncologynurseadvisor.com
Most Recently Shared on May 10, 2011 at 2:51 pm By:
OncologyNurseAdvisor Medical Education, Medical Publisher, Oncology, and Nursing
Fluzone Intradermal Vaccine Approved for Influenza Immunization http://goo.gl/fb/8HN1R
Sanofi Pasteur Announces FDA Approval of Menactra Meningococcal Conjugate Vaccine Indication for Infants - Apr 22, 2011
sanofipasteurus.mediaroom.com — “Welcome to sanofi pasteur, Sanofi Pasteur US Media Center, the vaccines division of sanofi-aventis Group, is the largest company in the world devoted entirely to human vaccines.” View full resource at sanofipasteurus.mediaroom.com
Most Recently Shared on April 26, 2011 at 8:43 am By:
Sanofi Pasteur Announces FDA Approval of #Menactra Meningococcal Conjugate #Vaccine Indication for Infants. http://ow.ly/4GYoo
Menactra Gains Indication for Immunization of Infants - ONA
oncologynurseadvisor.com — “The FDA has expanded the indication for Menactra (meningococcal [Groups A, C, Y and W-135] polysaccharide diphtheria toxoid conjugate vaccine; Sanofi Pasteur) to include a two-dose schedule for infants and children 9--23 months old.” View full resource at oncologynurseadvisor.com
Most Recently Shared on April 25, 2011 at 7:05 pm By:
OncologyNurseAdvisor Medical Education, Medical Publisher, Oncology, and Nursing
Menactra Gains Indication for Immunization of Infants http://goo.gl/fb/9NRz4
FDA Approval Of Menactra Meningococcal Conjugate Vaccine Indication For Infants Announced By Sanofi Pasteur
medicalnewstoday.com — “Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced today that the U.S. Food and Drug Administration (FDA) has granted licensure to expand th” View full resource at medicalnewstoday.com
Most Recently Shared on April 25, 2011 at 4:05 pm By:
FDA Approval Of Menactra Meningococcal Conjugate Vaccine Indication For Infants Announced By Sanofi Pasteur http://mnt.to/3TYW
Menactra Gains Indication for Immunization of Infants - MPR
empr.com — “The FDA has expanded the indication for Menactra (meningococcal [Groups A, C, Y and W-135] polysaccharide diphtheria toxoid conjugate vaccine; Sanofi Pasteur) to include a two-dose schedule for infants and children 9--23 months old.” View full resource at empr.com
Most Recently Shared on April 25, 2011 at 2:19 pm By:
MPR News: Menactra Gains Indication for Immunization of Infants: The FDA has expanded the indication for Menactr... http://bit.ly/ew0S93
Sanofi Pasteur receives FDA approval for Menactra to prevent meningococcal disease
news-medical.net — “The U.S. Food and Drug Administration today approved the use of Menactra in children as young as 9 months for the prevention of invasive meningococcal disease caused by Neisseria meningitidis serogroups A, C, Y and W-135. Menactra already is approved for use in people ages 2 through 55 years.” View full resource at news-medical.net
Most Recently Shared on April 25, 2011 at 4:10 am By:
Sanofi Pasteur receives FDA approval for Menactra to prevent meningococcal disease: The U.S. Food and Drug Admin... http://bit.ly/hGpsIA
FDA accepts Sanofi Pasteur's Menactra vaccine sBLA for active immunization of infants and toddlers
news-medical.net — “Sanofi Pasteur, the vaccines division of the sanofi-aventis Group, announced today that the U.S. Food and Drug Administration (FDA) has accepted for review a supplemental Biologics License Application (sBLA) for use of Menactra® (Meningococcal [Groups A, C, Y and W-135] Polysaccharide Diphtheria Toxoid Conjugate Vaccine) for active immunization of infants and toddlers for the prevention of invasive meningococcal disease caused by serogroups A, C, Y, and W-135.” View full resource at news-medical.net
Most Recently Shared on August 27, 2010 at 11:34 am By:
Meningitis News: FDA accepts Sanofi Pasteur's Menactra vaccine sBLA for active immunization of infants and toddler... http://bit.ly/doRVE7
FDA accepts sBLA for Menactra for immunization of infants and toddlers - MPR
empr.com — “Sanofi Pasteur announced that the FDA has accepted for review a supplemental Biologics License Application (sBLA) for the use of Menactra (Meningococcal [Groups A, C, Y and W-135] polysaccharide diphtheria toxoid conjugate vaccine) for active immunization of infants and toddlers for the prevention of invasive meningococcal disease caused by serogroups A, C, Y, and W-135.” View full resource at empr.com
Most Recently Shared on August 26, 2010 at 2:46 pm By:
MPR News: FDA accepts sBLA for Menactra for immunization of infants and toddlers: Sanofi Pasteur announced that th... http://bit.ly/dsE6tE
FDA Accepts Sanofi Pasteur's Application to Expand Indication of Menactra Vaccine to Infants and Toddlers - FiercePharma
fiercepharma.com — “FDA Accepts Sanofi Pasteur's Application to Expand Indication of Menactra® Vaccine to Infants and Toddlers New Indication Seeks to Help Protect Infants and Toddlers Against Meningococcal... Read more...” View full resource at fiercepharma.com
Most Recently Shared on August 26, 2010 at 2:38 pm By:
FDA Accepts Sanofi Pasteur's Application to Expand Indication of Menactra® Vaccine to Infants and Toddlers. http://bit.ly/bnN5Cn
FDA accepts sBLA for Menactra for immunization of infants and toddlers - ONA
oncologynurseadvisor.com — “Sanofi Pasteur announced that the FDA has accepted for review a supplemental Biologics License Application (sBLA) for the use of Menactra (Meningococcal [Groups A, C, Y and W-135] polysaccharide diphtheria toxoid conjugate vaccine) for active immunization of infants and toddlers for the prevention of invasive meningococcal disease caused by serogroups A, C, Y, and W-135.” View full resource at oncologynurseadvisor.com
Most Recently Shared on August 26, 2010 at 2:33 pm By:
OncologyNurseAdvisor Medical Education, Medical Publisher, Oncology, and Nursing
FDA accepts sBLA for Menactra for immunization of infants and toddlers http://goo.gl/fb/3I831
U.S. FDA Licenses Sanofi Pasteur's Pandemic Influenza Vaccine
medicalnewstoday.com — “Sanofi Pasteur, the vaccines division of the sanofi-aventis Group (EURONEXT: SAN and NYSE: SNY), announced that the U.S. Food and Drug Administration (FDA) has approved the company's supplemental” View full resource at medicalnewstoday.com
Most Recently Shared on September 16, 2009 at 1:52 pm By:
MNT Swine Flu News Health News
U.S. FDA Licenses Sanofi Pasteur's Pandemic Influenza Vaccine: Sanofi Pasteur, the vaccines division of the sano.. http://bit.ly/5tmNY
Advertisement
